Literature DB >> 29975037

Primary Sjögren’s Syndrome.

Sean Lal1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29975037     DOI： 10.1056/NEJMc1804598

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model.

Authors:  Yifan Wang; Ruiling Feng; Gong Cheng; Bo Huang; Jiayi Tian; Yuzhou Gan; Yuebo Jin; Miao Miao; Xia Zhang; Xiaolin Sun; Jing He; Zhanguo Li
Journal:  Front Med (Lausanne)       Date:  2022-05-19

Review 2.  Immune Monitoring upon Treatment with Biologics in Sjögren's Syndrome: The What, Where, When, and How.

Authors:  Joyce J B C van Beers; Jan G M C Damoiseaux
Journal:  Biomolecules       Date:  2021-01-16

3.  Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4+ T Lymphocytes and a Landscape of Immune Cells in Primary Sjögren's Syndrome.

Authors:  Xiaoping Hong; Shuhui Meng; Donge Tang; Tingting Wang; Liping Ding; Haiyan Yu; Heng Li; Dongzhou Liu; Yong Dai; Min Yang
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

4.  Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren's Syndrome Based on the PI3K/Akt/HIF-1α/VEGF Signaling Pathway.

Authors:  Ping Zeng; Wei Liu; Xiaochun Yang; Shumin Zhang; Shaopeng Du; Yihua Fan; Longmei Zhao; Aihua Wang
Journal:  Dis Markers       Date:  2022-01-31       Impact factor: 3.434

Review 5.  Single Cell RNA Sequencing in Autoimmune Inflammatory Rheumatic Diseases: Current Applications, Challenges and a Step Toward Precision Medicine.

Authors:  Tadeja Kuret; Snežna Sodin-Šemrl; Brane Leskošek; Polonca Ferk
Journal:  Front Med (Lausanne)       Date:  2022-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.